Document is current
Any future updates will be listed below
-
Authors
Ferrao-Malheiro, S.
Fabre, R.
Jiacomini, T.
Lanteri-Minet, M.
-
Funding
Funding for this research was provided by:
FHU InovPain
- License Information
-
More Information
Article History
Received: 1 May 2026
Accepted: 11 June 2026
First Online: 29 July 2026
Declarations
Ethic approval and consent to participate: This observational study did not require approval from the ethics committee. It was conducted as part of the FHU InovPain registry clinical research program, which received authorization from the French National Commission on Informatics and Liberty (Commission Nationale de l’Informatique et des Libertés; CNIL; CIL register no. 278, dated 11/09/2017). Patients were included only after providing written informed consent allowing their data recorded in the FHU InovPain registry database to be used for clinical research purposes.
Consent for publication: Not applicable.
Competing interests: SFM has no conflict of interest.RF had no conflict of interest.TJ had no conflict of interest.MLM received personal fees for consultancy activities from: Abbvie/Allergan, Amgen, Eli Lilly, IPSEN, Lundbeck, Medtronic, Novartis, Orion Pharma, Perfood, Pfizer, Reckitt-Benckiser, Savia, Bioelectronics, Teva, UPSA.
